Financial Performance - The reported net profit for the year ending December 31, 2025, is $7,104,000, compared to $2,508,000 for the previous year, representing a significant increase of 184%[2] - Adjusted net profit (non-IFRS measure) for the same period is $9,498,000, up from $7,547,000, reflecting a growth of 25.8%[2] - Total revenue for the year is $109,399,000, an increase from $107,452,000, indicating a growth of 1.8%[3] - Gross profit for the year is $32,635,000, compared to $30,851,000 in the previous year, marking an increase of 5.8%[3] - The company reported a pre-tax profit of $8,502,000, up from $4,214,000, which is an increase of 101.4%[3] - Basic earnings per share for the year is $1.39, compared to $0.49 in the previous year, reflecting a growth of 184%[3] - The company’s total comprehensive income for the year is $7,304,000, compared to $2,362,000 in the previous year, representing an increase of 208%[3] - The company reported a profit attributable to owners of $7,104,000 for 2025, a significant increase from $2,508,000 in 2024, representing a growth of 184.5%[31] - The basic earnings per share for 2025 is $13.93, compared to $4.94 in 2024, reflecting a significant increase of 182.4%[31] Revenue and Regional Performance - North America revenue is projected to decrease from $42,515 thousand in 2024 to $26,425 thousand in 2025, a decline of approximately 37.8%[13] - Europe revenue is expected to increase from $43,317 thousand in 2024 to $50,385 thousand in 2025, a growth of about 16.5%[13] - Asia revenue is forecasted to rise significantly from $13,986 thousand in 2024 to $26,805 thousand in 2025, an increase of approximately 91.5%[13] - Revenue breakdown by region for 2025: North America at $26,425 (24.2%), Europe at $50,385 (46.1%), Asia at $26,805 (24.5%), and Latin America at $5,784 (5.3%)[54] - Customer contract revenue totals $109,399 thousand in 2025, up from $107,452 thousand in 2024, reflecting a growth of about 1.8%[17] Expenses and Cost Management - The company incurred restructuring and redundancy costs of $386,000 in 2025, down from $1,102,000 in 2024, showing a reduction of 65%[2] - Legal expenses amounted to $2,008,000 in 2025, compared to $708,000 in 2024, indicating an increase of 183%[2] - The cost of goods sold for components increased from $63,708 thousand in 2024 to $66,561 thousand in 2025, representing a rise of approximately 4.4%[25] - Research and development expenses decreased from $5,688 thousand in 2024 to $4,215 thousand in 2025, a reduction of about 26.0%[25] - Selling and distribution expenses rose from approximately $7.3 million in 2024 to about $7.8 million in 2025, mainly due to increased employee benefits and professional fees[59] - Administrative expenses were approximately $12 million for both years ending December 31, 2025, and 2024[60] Assets and Liabilities - Total assets increased to $78,409,000 in 2025 from $68,491,000 in 2024, representing a growth of approximately 14.1%[4] - Current liabilities decreased to $32,941,000 in 2025 from $42,808,000 in 2024, a reduction of about 23.2%[4] - Non-current liabilities rose to $602,000 in 2025 from $510,000 in 2024, an increase of approximately 18.0%[5] - Total equity increased significantly to $44,866,000 in 2025 from $25,173,000 in 2024, reflecting an increase of about 78.5%[5] - Cash and cash equivalents amounted to $19,443,000 in 2025, up from $12,000,000 in 2024, indicating a growth of approximately 62.0%[4] - Trade receivables slightly increased to $23,764,000 in 2025 from $23,575,000 in 2024, a marginal rise of about 0.8%[4] - The company reported a net asset value of $34,524,000 in 2025, compared to $14,327,000 in 2024, marking an increase of approximately 141.5%[4] Taxation - The total income tax expense for 2025 is $1,398,000, a decrease of 18.0% from $1,706,000 in 2024[7] - The effective tax rate for 2025 is 16.4%, a decrease from 40.5% in 2024, reflecting improved tax efficiency[7] - The company’s federal tax rate remains stable at 21% for 2025, consistent with 2024[27] Corporate Governance and Management - The company is committed to establishing good corporate governance practices to enhance transparency and accountability to shareholders[100] - The board is actively seeking a suitable candidate to fill the vacancy of the non-executive director position following the resignation of Alain Perrot[101] - The company will continue to review and improve its corporate governance practices to ensure effective leadership and enhance shareholder returns[102] - All directors have confirmed compliance with the standard code of conduct regarding securities trading as of December 31, 2025[103] - The company established an audit committee consisting of three independent non-executive directors to oversee financial reporting and risk management[104] Strategic Initiatives and Future Plans - The company plans to allocate around 70% of the net proceeds from a recent share placement to the development of AIoT technology and personal healthcare management products[47] - The company has established a wholly-owned subsidiary, Orbiva Limited, to further expand its healthcare business[46] - The company aims to enhance operational efficiency and profitability through strategic adjustments and by expanding its product lines with higher profit margins[48] - The company is focusing on cost management, expanding its sales team, and investing in R&D to diversify its business, particularly in home healthcare[51] - The company plans to develop AIoT technology and products, with a budget allocation of HKD 15.95 million (USD 2.05 million) for the first milestone, expected to be utilized by March 2026[92] Shareholder Information - The proposed final dividend for the fiscal year ending December 31, 2025, is $0.66 per share, totaling $3,552,000, pending approval at the upcoming annual general meeting[40] - A final dividend of USD 0.66 per share (approximately HKD 5.19 per share) has been proposed for the year ending December 31, 2025, compared to USD 0.25 per share (approximately HKD 1.93 per share) for the previous year[98] Market and Economic Conditions - The company has not utilized funds originally allocated for R&D and development of OTT products due to the unstable economic environment caused by COVID-19[88] - The company anticipates that the utilization of IPO proceeds will further improve its overall business performance[90] - The group continues to monitor foreign exchange risks and will take prudent measures to minimize currency exchange risks[83] - The group anticipates continued fluctuations in the exchange rates of the Singapore dollar, Chinese yuan, and US dollar[83]
HOME CONTROL(01747) - 2025 - 年度业绩